tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steven Breazzano, 4 are a HOLD (44.44%), 5 are a BUY (55.56%).
Analyst Steven Breazzano, carries an average stock price target met ratio of 100% that have a potential upside of 31% achieved within 163 days. Previously, Steven Breazzano worked at PIPER SANDLER.
Steven Breazzano’s has documented 19 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on RARE, Ultragenyx at 23-Mar-2017.
Analyst best performing recommendations are on MRTX (MIRATI THER).
The best stock recommendation documented was for MRTX (MIRATI THER) at 6/3/2016. The price target of $14 was fulfilled within 3 days with a profit of $4.35 (23.71%) receiving and performance score of 79.02.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 14-Jun-2022
3 years 9 months 26 days ago
(14-Jun-2022)
0/13 (0%)
$2.53 (172.11%)
Hold Since 30-Oct-2018
$4.75
$4.66 (5177.78%)
$5.75
4 years 5 months 6 days ago
(03-Nov-2021)
8/10 (80%)
$0.06 (1.28%)
66
Sell Since 20-May-2020
$3
$2.91 (3233.33%)
5 years 5 months 3 days ago
(06-Nov-2020)
3/5 (60%)
$-1.26 (-29.58%)
151
Buy Since 09-May-2018
$16
$15.91 (17677.78%)
$17
5 years 8 months 2 days ago
(07-Aug-2020)
4/11 (36.36%)
$10.58 (195.20%)
88
Sell Since 08-Oct-2019
5 years 11 months 3 days ago
(06-May-2020)
0/2 (0%)
$25.85 (43.70%)
What Year was the first public recommendation made by Steven Breazzano?
